Spinning out breakthrough medical, veterinary, and dual-use technology companies from a proven proprietary electromagnetic platform — faster, smarter, and more capital-efficiently than anyone else.
Forma.Ventures is a deep-tech venture creation platform advancing breakthrough medical and veterinary technologies in imaging, robotics, and intelligent systems. Our mission: make sophisticated diagnostic and therapeutic tools more compact, affordable, and accessible worldwide.
Most medical imaging systems remain large, expensive, and infrastructure-dependent — placing them out of reach for community hospitals, developing countries, and specialized care facilities. Despite rapid global demand, innovation has been incremental, leaving a massive access and affordability gap.
We bridge this gap with an integrated engineering lab, venture-creation expertise, and capital-efficient modular hardware systems rapidly reconfigured for multiple clinical and dual-use applications. Capital, innovation, and execution are tightly aligned from inception through scale.
Generates IP and prototypes platform technologies. Our proprietary modular electromagnetic system spans MRI, robotics, neuromodulation, and defense applications.
Develops commercialization strategies, regulatory pathways, and founding teams — achieving clinical validation in months rather than years.
Leverages outside capital once ventures are de-risked. By creating companies at lower valuations, we deliver superior risk-adjusted returns vs. traditional VC.
Active partnerships on 3 continents — Philips (Netherlands), MicroPort (China), Radialis Medical (Canada), and CMR Molecular Imaging (Mexico).
Led by a practicing radiologist and pulsed power physicist with 100+ patents, our core team of 20 engineers, scientists, and commercialization experts brings over a century of collective experience in medical systems — from hand-held PET scanners to full-scale proton therapy equipment.
Pioneering non-invasive transcranial magnetic stimulation to repair the memory connections lost in Alzheimer's disease and dementia — addressing one of the most urgent unmet needs in modern medicine with no current disease-modifying therapy.
MR imaging and MRI-guided robotic surgical systems for veterinary patients — a compact, cryogen-free platform that fits any clinic. Not FDA regulated, already selling into market through the prior LongMile spinout.
Next-generation power storage delivering 1000× power density improvements for defense, fusion energy, and electric vehicles — built on the same electropermanent magnetics platform as our medical applications.
We are engaging a select group of family offices, strategic investors, and high-net-worth individuals who share our vision for building the next generation of medtech and healthtech ventures.
Fund I's initial close of $5 million finances the first wave of spinouts, followed by subsequent closes to reach $100 million over three years — each spinout entering market with validated technology and a clear path to commercialization.